CW (NYSE: CW) Form 144: RSU vesting and recent insider dispositions

Rhea-AI Filing Summary

CW filed a Form 144 reporting a proposed sale of 1,265 shares of Common Stock through UBS Financial Services (NYSE) tied to an RSU vesting on 03/16/2026.

The filing names K. Christopher Farkas and lists prior dispositions in the past three months: 3,105 shares sold on 02/18/2026 for $2,156,439.58 and 2,665 shares sold on 02/04/2026 for $1,669,034.61.

Insights

Securities Attorney

Form 144 discloses disposition activity tied to RSU vesting and recent sales.

The filing shows an RSU vesting event dated 03/16/2026 and a proposed sale of 1,265 Common shares through UBS Financial Services. It also reports prior arm's-length dispositions of 3,105 and 2,665 shares on 02/18/2026 and 02/04/2026 with the proceeds listed.

Timing and cash‑flow treatment are stated as proceeds amounts next to each past sale. Subsequent filings or broker confirmations would show whether the proposed sale executed; future disclosures may provide execution details.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	1265	861831.85	36869530	03/18/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/16/2026	RSU Vesting	Issuer			1265	03/16/2026	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
K. Christopher Farkas 130 Harbour Place Drive Suite 300 Davidson NC 28036	Common	02/18/2026	3105	2156439.58
K. Christopher Farkas 130 Harbour Place Drive Suite 300 Davidson NC 28036	Common	02/04/2026	2665	1669034.61

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the CW Form 144 report?

The filing reports a proposed sale of 1,265 Common shares tied to an RSU vesting on 03/16/2026. It also lists prior sales of 3,105 and 2,665 shares in February 2026 with proceeds shown.

Who is the reporting person on the CW Form 144?

The filing names K. Christopher Farkas as the reporting person. The entry includes an address and shows recent dispositions dated 02/18/2026 and 02/04/2026 with associated proceeds.

How were the prior CW share sales documented?

Prior dispositions are listed as sales: 3,105 shares on 02/18/2026 for $2,156,439.58 and 2,665 shares on 02/04/2026 for $1,669,034.61, as shown in the filing's past three months section.

Is the proposed CW sale already executed?

The Form 144 shows a proposed sale of 1,265 shares tied to RSU vesting on 03/16/2026. The filing does not state execution confirmation; subsequent broker reports or filings would confirm whether the sale occurred.

Which broker is handling the CW transaction?

The broker listed is UBS Financial Services Inc, with an address at 1000 Harbor Blvd, Weehawken, NJ. The filing associates UBS with the listed securities and the proposed sale activity.